Zimbabwe Eyecare And Learning(ZEAL):Formative Research on Hyperopia and Educational Outcomes in Primary School Children

NCT05538182 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1883

Last updated 2024-03-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether uncorrected or corrected long-sightedness (hyperopia) has an impact on reading skills, in Grade 2 or Grade 4 school-aged children from Mashonaland Central province of Zimbabwe, compared to age-, gender- and school-matched children with no refractive error (emmetropia), measured by the Happy Readers V4 reading tool over six months.

Conditions

  • Hyperopia
  • Long Sight

Interventions

DEVICE

Spectacles

Based on the refraction results, study participants diagnosed with refractive error will be dispensed two free pairs of distance spectacles.

Sponsors & Collaborators

  • L.V. Prasad Eye Institute

    collaborator OTHER
  • University of Zimbabwe

    collaborator OTHER
  • University of Ulster

    collaborator OTHER
  • New England College of Optometry

    collaborator OTHER
  • Peek Vision

    collaborator UNKNOWN
  • Zimbabwe Optometric Association

    collaborator UNKNOWN
  • Clearly

    collaborator OTHER
  • Christian Blind Mission

    collaborator UNKNOWN
  • Queen's University, Belfast

    lead OTHER

Principal Investigators

  • Nathan G Congdon, MD, MPH · Queen's University, Belfast

  • Rohit C Khanna, MPH · L.V. Prasad Eye Institute

  • Lynett E Masiwa, MSc · University of Zimbabwe

  • Rangarirai Masanganise · University of Zimbabwe

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-07-28
Completion
2023-07-28

Countries

  • Zimbabwe

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538182 on ClinicalTrials.gov